AMRX Amneal Corp: Enterprise Value to EBITDA Ratio

amneal.com (AMRX) - corporate logo

The EV/EBITDA valuation multiple for capital-intensive businesses on GURU.Markets illustrates the valuation dynamics of Amneal Pharmaceuticals (AMRX), where 14.81 represents the current metric. Management is effectively neutralizing pricing pressure in generics by optimizing costs and reducing debt. Growth is driven by complex injectables and biosimilars, while an updated pipeline is lifting the company out of stagnation by expanding its presence in the CNS and endocrinology segments.

Amneal Pharmaceuticals, Inc. - AMRX Business Value to Operating Income Before Depreciation (period 11/23/2025 - 11/16/2026)

Comprehensive metric breakdowns and analytics for Amneal (AMRX)

Fundamental company analysis:AMRX (amneal.com)
Original product of amneal.com

Given the debt load and pricing pressure in the generics segment of Amneal Pharmaceuticals (AMRX), the company's EV/EBITDA chart becomes a key tool for monitoring business value relative to its operating profit. This multiple combines market capitalization and net debt, allowing investors to assess the real payback period of assets without tax distortions or financing structure biases.

Competitors of Amneal Pharmaceuticals (AMRX)

Haleon Group - Enterprise Value to EBITDA Ratio|Kenvue (KVUE) - Company Value to EBITDA|VRNA: Enterprise Value to EBITDA Ratio|Jyong Biotech - Enterprise Value to Operating Income Before Depreciation Ratio|LGND: EV/EBITDA Multiple|Perrigo Company - Business Value to Operating Income Before Depreciation|ALVO (Alvotech S.A.) - EV/EBITDA Multiple|Company Value to EBITDA liquidia.com LQDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Galapagos (GLPG)|ANIP (ANI Pharmaceuticals, Inc.) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Afrezza MNKD|EV/EBITDA Multiple Amphastar Corp AMPH|Pacira Corp - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation SPRY (ars-pharma.com)|TBPH: EV/EBITDA Multiple|Aquestive Therapeutics, Inc. (AQST) - EV/EBITDA Multiple|SCPH (scpharmaceuticals.com) - EV/EBITDA Multiple|TECX (tectonictx.com) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TNXP (Tonix Pharmaceuticals Holding Corp.)|EV/EBITDA Multiple SXT China (SXTC)|eupraxiapharma.com - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation BHST|invizyne.com - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation ORMP (Oramed Pharmaceuticals Inc.)|ENTX: EV/EBITDA Multiple|MindWalk Holdings Inc. (HYFT) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ABVC BioPharma|Enterprise Value to Operating Income Before Depreciation CPIX (Cumberland Pharmaceuticals Inc.)|EV/EBITDA Multiple QNTM|Total Company Value to Operating Income Before Depreciation Ratio FibroGen Corporation|EV/EBITDA Multiple TELO (Telomir Pharmaceuticals Corp)|RANI (Rani Therapeutics Inc) - Company Value to Operating Income Before Depreciation Ratio|SNYR: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation RLYB (Rallybio)|LEXX: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulmatrix, Inc.|PTHL (Pheton Holdings Ltd) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization APM|EV/EBITDA Multiple LYRA|EV/EBITDA Multiple Impact BioMedical, Inc. (IBO)|EV/EBITDA Multiple TNFA (TNF Pharmaceuticals)|Business Value to Operating Income Before Depreciation YCBD|PRFX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CYTO - EV/EBITDA Multiple|LIPO (Lipella Pharmaceuticals) - Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio OPTN (OptiNose)|PIRS (Pieris Pharma) - EV/EBITDA Multiple|Procaps Group Corp - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PTPI|qlsyy.net (QLI) - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ACELYRIN SLRN|TFFP (TFF Pharmaceuticals, Inc.) - Company Value to Operating Income Before Depreciation Ratio